Senores Pharmaceuticals Limited (“SPL”), through its wholly-owned subsidiary Senores Pharmaceuticals, Inc., USA (“SPI”), has signed agreements today to acquire a basket of 14 Abbreviated New Drug Applications (‘ANDAs’) from Dr. Reddy’s Laboratories and its applicable affiliates (BSE: 500124 | NSE: DRREDDY | NYSE: RDY |
OneSource Specialty Pharma Limited today announced the appointment of three new non-executive independent directors to its Board — Dr. Claudio Albrecht, Ms. Debarati Sen and Mr. Vijay Karwal—effective February 27, 2025. The directors bring decades of leadership experience and expertise in Pharma, Business Strategy, Transformation,
From Microsoft & Medtronic to WHO and Johnson & Johnson, Asia’s biggest biotechnology conference announces a diverse range of experts from technology and healthcare industries Conference to host about 50 speakers, participating across in 7 panels, 2 keynote addresses, a CEO Conclave and a
Leading drug makers Dr Reddy's Laboratories and Zydus Pharma are recalling bottles of a product each, in the US market, for different reasons, according to the latest report of the US health regulator. Dr Reddy's Laboratories, Inc, the US arm of Dr Reddy's Laboratories, is
Dr Reddy’s Laboratories which has soft-launched Russia’s COVID-19 vaccine Sputnik V here has expanded the pilot which is in the final leg to other cities such as Mumbai, Bangalore and New Delhi. Presently it being a limited pilot phase, registration on CoWIN is not open for
